Nu 51:(nyt ofatumumab studie)
-
Nu 51:(nyt ofatumumab studie)
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
This study is not yet open for participant recruitment.
Verified by UNC Lineberger Comprehensive Cancer Center, December 2010
First Received: December 16, 2010 Last Updated: December 17, 2010
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind